Could Vitamin D Have a Potential Anti-Inflammatory and Anti-Infective Role in Bronchiectasis?
- 31 January 2013
- journal article
- research article
- Published by Springer Nature in Current Infectious Disease Reports
- Vol. 15 (2) , 148-157
Abstract
Bronchiectasis is a chronic infective and inflammatory respiratory disease that causes significant morbidity and mortality. Patients with non-cystic-fibrosis bronchiectasis are frequently vitamin D deficient, and vitamin D levels correlate with disease severity. Infection-specific actions of vitamin D include the enhancement of innate immunity and the moderation of inflammation caused by the adaptive immune response. Potentially, vitamin D could influence the processes that lead to bronchiectasis and the frequency and severity of acute exacerbations. Randomized trials of vitamin D supplementation have shown effects that are likely to be protective against the development of bronchiectasis. Several issues need to be clarified before the development of clinical trials to investigate the role of vitamin D in bronchiectasis. These include an optimal vitamin D supplementation dose and appropriate and sensitive outcome measures that include assessment of exacerbation frequency and severity, lung function, and health-related quality of life.Keywords
This publication has 100 references indexed in Scilit:
- Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatmentProceedings of the National Academy of Sciences, 2012
- Effect on the incidence of pneumonia of vitamin D supplementation by quarterly bolus dose to infants in Kabul: a randomised controlled superiority trialThe Lancet, 2012
- Cord blood 25-hydroxyvitamin D levels are associated with aeroallergen sensitization in children from Tucson, ArizonaJournal of Allergy and Clinical Immunology, 2011
- Staphylococcus aureus nasal carriage is associated with serum 25-hydroxyvitamin D levels, gender and smoking status. The Tromsø Staph and Skin StudyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2011
- Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program studyJournal of Allergy and Clinical Immunology, 2010
- How regulatory T cells workNature Reviews Immunology, 2008
- Vitamin D DeficiencyNew England Journal of Medicine, 2007
- CorrespondenceEpidemiology and Infection, 2007
- Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?Nature Reviews Microbiology, 2005
- Antimicrobial peptides of multicellular organismsNature, 2002